CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company
Foghorn Therapeutics Inc.
Sign in to watch- Ticker
- FHTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-586-3100
- Business address
- 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-13 | Flagship Pioneering, LLC Director | Grant or award · Pre-Funded Warrants to purchase Common Stock | +2,235,468 | $6.71 | $15.0M | 2,235,468 |
| 2026-01-13 | Flagship Pioneering, LLC Director | Grant or award · Series 1 Warrants to purchase Common Stock | +1,117,734 | 1,117,734 | ||
| 2026-01-13 | Flagship Pioneering, LLC Director | Grant or award · Series 2 Warrants to purchase Common Stock | +1,117,734 | 1,117,734 | ||
| 2025-06-17 | SMITH IAN F Director | Grant or award · Stock Option (right to buy) | +25,000 | $4.79 | $120K | 25,000 |
| 2025-06-17 | PARSHALL B LYNNE Director | Grant or award · Stock Option (right to buy) | +25,000 | $4.79 | $120K | 25,000 |
| 2025-06-17 | Mendelsohn Michael Director | Grant or award · Stock Option (right to buy) | +25,000 | $4.79 | $120K | 25,000 |
| 2025-06-17 | Lynch Thomas J. Jr. Director | Grant or award · Stock Option (right to buy) | +25,000 | $4.79 | $120K | 25,000 |
| 2025-06-17 | GILL SIMBA Director | Grant or award · Stock Option (right to buy) | +25,000 | $4.79 | $120K | 25,000 |
| 2025-06-17 | Biller Scott Director | Grant or award · Stock Option (right to buy) | +25,000 | $4.79 | $120K | 25,000 |
| 2025-06-17 | Cole Douglas G. Director | Grant or award · Stock Option (right to buy) | +25,000 | $4.79 | $120K | 25,000 |
| 2025-05-01 | Gallagher Neil Director | Grant or award · Stock Options (Right to buy) | +50,000 | $4.16 | $208K | 50,000 |
| 2025-05-01 | Duty Stuart Director | Grant or award · Stock Options (Right to buy) | +50,000 | $4.16 | $208K | 50,000 |
| 2025-04-25 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | −300,000 | 511,704 | ||
| 2025-04-25 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | +300,000 | 511,704 | ||
| 2025-04-09 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | −197,906 | 511,704 | ||
| 2025-04-09 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | +197,906 | 511,704 | ||
| 2025-01-22 | Cardama Alfonso Quintas Chief Medical Officer | Grant or award · Stock Option (right to buy) | +125,000 | $4.37 | $546K | 125,000 |
| 2025-01-22 | Humer Kristian Chief Financial Officer | Grant or award · Stock Option (right to buy) | +120,000 | $4.37 | $524K | 120,000 |
| 2025-01-22 | Costa Carlos Chief People Officer | Grant or award · Stock Option (right to buy) | +115,000 | $4.37 | $503K | 115,000 |
| 2025-01-22 | Rivkin Anna Chief Business Officer | Grant or award · Stock Option (right to buy) | +50,000 | $4.37 | $219K | 50,000 |
Page 2 of 9 · 177 trades